Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 9.73923 | 98 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 10.2162 | 98 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 9.97977 | 98 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.1629 | 98 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.1336 | 98 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 9.67452 | 98 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 9.73646 | 98 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 10.2538 | 98 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 10.3618 | 98 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.2144 | 98 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 9.91708 | 98 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.1319 | 98 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 9.94924 | 98 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.0551 | 98 |